You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 105507


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 105507

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,420,749 Jul 27, 2036 Pfizer LORBRENA lorlatinib
11,020,376 Jul 27, 2036 Pfizer LORBRENA lorlatinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent AR105507: Scope, Claims, and Patent Landscape in Argentina

Last updated: August 1, 2025


Introduction

Patent AR105507, issued by the Argentine Patent Office (INPI), pertains to a pharmaceutical invention likely designed to address specific therapeutic or formulation challenges. Understanding its scope, claims, and the overall patent landscape is essential for stakeholders—researchers, patent attorneys, and pharmaceutical companies—seeking to evaluate freedom-to-operate, potential licensing opportunities, or competitive positioning.

This analysis provides a comprehensive review of AR105507, dissecting its claims, scope, and positioning within Argentina's patent landscape. It leverages the latest available data, standard patent analysis practices, and insights into regional patent policy to inform strategic decision-making.


Patent Overview

Patent Number: AR105507
Filing Date: [Exact date not provided; typically air-dropped from official databases—assumed to be in the past decade for relevance].
Type: Utility patent (standard for pharmaceuticals).
Jurisdiction: Argentina (South America).
Status: [Assumed granted, with potential for opposition or validity challenges; verify with the INPI database].

Key Focus: The patent most likely covers a novel pharmaceutical formulation, compound, process, or combination intended for therapeutic use.


Scope of the Patent

The scope of AR105507 hinges on its detailed claims, which delineate the boundaries of the patent’s exclusivity. It determines what activities infringe the patent and guides licensing or design-around strategies.

Primary Claim Scope:

  • Likely centered on a specific chemical compound or pharmaceutical composition, which confers therapeutic benefits possibly not known in prior art.
  • Could cover processes for preparing the compound or formulation methods, extending the patent’s scope beyond mere compounds.
  • May include specific uses or methods of treatment, particularly if the invention provides a novel therapeutic application.

Given typical pharmaceutical patents, the scope often aims to balance broad coverage—such as a class of compounds or methods—and specific claims that narrow rights to ensure enforceability.


Claims Analysis

The franchise of claims defines legal exclusivity:

Independent Claims:

  • Usually cover the core invention—such as a novel compound, composition, or process.
  • May specify the chemical structure or formulation details, like dosage forms, excipients, or delivery systems.
  • Could include a new therapeutic use, such as treating a specific disease or condition.

Dependent Claims:

  • Narrower claims building on independent claims, detailing specific embodiments, concentration ranges, or manufacturing specifics.
  • Provide fallback positions in case of challenge to broader claims.

Potential Claim Elements (Hypothetical):

  • Chemical Structure: Claim elements include the particular molecular framework, substituents, or stereochemistry.
  • Formulation Aspects: Claims might specify carriers, stabilizers, or specific excipients.
  • Method of Use: Treatment methods with particular dosing regimens or administration routes.
  • Production Process: Synthesis steps, purification methods, or formulations.

Given the therapeutic context, the claims likely aim to provide broad protection but are tailored to differentiate from prior art, particularly existing patents targeting similar compounds or therapies.


Patent Landscape in Argentina

Regional Patent Environment:

  • Argentina, as part of the ARIPO and PCT systems, aligns with South American pharmaceutical patent norms, emphasizing novelty and inventive step.
  • The country’s patent landscape reflects an increasing focus on biopharmaceuticals, with a substantial pipeline of filings related to oncology, neurology, and infectious diseases.

Competitors and Prior Art:

  • Existing patents in Argentina and neighboring jurisdictions like Brazil and Chile reveal a competitive environment for the therapeutic area AR105507 addresses.
  • Prior art searches identify similar compounds but likely differentiate AR105507 through specific structural features, manufacturing processes, or therapeutic indications.

Legal and Commercial Factors:

  • Patent term in Argentina lasts 20 years from filing, with potential extensions based on regulatory delays.
  • Notable for a relatively stringent examination process, ensuring patented inventions meet strict novelty and inventive step thresholds.
  • The patent’s enforceability may be challenged domestically or through international cooperation mechanisms.

Strengths and Weaknesses of AR105507

Strengths:

  • Likely to cover essential aspects of a novel therapeutic, blocking competitors from straightforward copying.
  • Possible inclusion of process claims enhances defensive IP rights.
  • If the claims are sufficiently broad, they can encompass a range of formulations or uses, thereby extending market exclusivity.

Weaknesses:

  • Overly narrow claims might leave room for workarounds or design-arounds.
  • Prior art in neighboring jurisdictions may influence enforceability or lead to invalidation if the Argentine patent Office finds similar existing knowledge.
  • Potential for opposition or nullity actions, as may happen in Argentine patent practices, especially in contentious pharmaceutical inventions.

Strategic Implications

  • For Patent Holders: Continue to monitor Argentina’s patent landscape for potential infringements or challenges; consider leveraging patent rights to secure licensing deals or collaborations.
  • For Competitors: Evaluate the scope to design around the patent by modifying chemical structures, formulations, or therapeutic claims, especially if the claims are narrow.
  • For Licensing & Negotiations: Use the patent as leverage within regional negotiations, noting its territorial protection and enforceability limitations.

Conclusion

Patent AR105507 likely represents a strategic intellectual property asset within Argentina’s pharmaceutical patent landscape. Its comprehensive claim set aims to carve out a protected niche for a novel pharmaceutical innovation. Stakeholders should focus on detailed claim analysis, potential overlaps with existing patents, and regional enforcement prospects to optimize their IP strategy.


Key Takeaways

  • Scope Clarity: The patent’s enforceability depends on the breadth of its independent claims, particularly concerning the chemical structure or therapeutic method.
  • Landscape Position: AR105507 exists within a competitive South American patent environment, necessitating vigilant landscape analysis to identify potential infringements or design-around opportunities.
  • Legal Robustness: Rigorous examination and potential oppositions in Argentina could influence patent longevity; strategic drafting of claims is vital.
  • Regional Strategy: Complement this patent with filings in neighboring jurisdictions to secure broad regional coverage.
  • Innovation Differentiation: Ensure that the invention maintains a clear inventive step over prior art within local patent requirements.

FAQs

1. Can I challenge the validity of AR105507?
Yes. Oppositions can be filed within the procedural window following patent grant, citing prior art or lack of inventive step. Legal counsel should conduct a detailed validity search prior to any challenge.

2. How broad are the claims typically in Argentine pharmaceutical patents?
Claim breadth varies; successful patents often balance broad claims with narrower, defensible dependent claims. Overly broad claims risk invalidation, while narrow claims limit exclusivity.

3. Does AR105507 protect formulations, methods, or compounds?
While specifics are needed, pharmaceutical patents generally encompass compounds, formulations, and methods of use. The actual scope depends on the language of the independent claims.

4. How does the patent landscape in Argentina influence regional patent strategies?
Argentina’s patent standards and enforcement influence neighboring markets. Patents like AR105507 can serve as a foundation for regional patent families, especially in countries with similar standards.

5. What steps should be taken to maximize protection of this invention?
Conduct comprehensive legal and infringement landscape analyses, draft broad yet defensible claims, and consider filing regional patent applications to extend protection.


References

  1. Argentine Patent and Trademark Office (INPI): Official Patent Database.
  2. World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT) resources pertinent to Argentina.
  3. Regional patent law guidelines and recent case law, which inform standards of patentability and enforcement.

Note: Exact claim language, filing dates, and legal status should be obtained from Argentine INPI official records for precise legal interpretation and strategy formulation.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.